Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Effects Toxics”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00317798
What this trial is testing

Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganMultiple Myeloma and Plasma Cell Neoplasm
University of Rochester 18
Not applicableNot Yet RecruitingNCT07408713
What this trial is testing

Neurocognitive Deficit After Paediatric Transplantation: Understanding the Role of Environment and Physical Function

Who this might be right for
HSCTPediatric CancerPediatric Patients+5 more
Rigshospitalet, Denmark 100
Not applicableLooking for participantsNCT05984888
What this trial is testing

Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer

Who this might be right for
Breast Cancer
Ohio State University Comprehensive Cancer Center 43
Not applicableUnknownNCT05414370
What this trial is testing

Hyperoxia Induced Pulmonary Inflammation and Organ Injury: a Human in Vivo Model

Who this might be right for
Oxygen ToxicityPulmonary InjuryAcute Lung Injury
Belfast Health and Social Care Trust 53
Post-approval studies (Phase 4)Study completedNCT00003252
What this trial is testing

Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
Rush North Shore Medical Center
Not applicableUnknownNCT03163147
What this trial is testing

The Effect and Frequency of Helicobacter Pylori Infection in Primary Immune Thrombocytopenic Patients

Who this might be right for
Effects Toxics
Assiut University 100
Not applicableUnknownNCT04461392
What this trial is testing

Exercise Response After Revalidation in Cancer Patients

Who this might be right for
OncologyCardiac Toxicity
Universitair Ziekenhuis Brussel 191
Testing effectiveness (Phase 2)Active Not RecruitingNCT04469075
What this trial is testing

Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields

Who this might be right for
GlioblastomaRecurrent GlioblastomaSkin Toxicity
Memorial Sloan Kettering Cancer Center 48
Post-approval studies (Phase 4)WithdrawnNCT03437330
What this trial is testing

Empagliflozin Effect on Glucose Toxicity

Who this might be right for
Type2 Diabetes Mellitus
University Hospital Tuebingen
Not applicableNot Yet RecruitingNCT03969693
What this trial is testing

Lymphoma Patients Undergoing Mediastinal Radiotherapy in the Era of Modern Chemoradiation

Who this might be right for
Mediastinal LymphomaHodgkin LymphomaNon Hodgkin Lymphoma
Chang Gung Memorial Hospital 50
Large-scale testing (Phase 3)Looking for participantsNCT06706544
What this trial is testing

Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy

Who this might be right for
Chemotherapy Induced Peripheral Neuropathy (CIPN)ParesthesiaNumbness+1 more
Bernardino Clavo, MD, PhD 42
Not applicableStudy completedNCT03480087
What this trial is testing

Subclinical Cardio-toxicities Evaluation With Strain Rate Echocardiography After Chemotherapy and/or Mediastinal Radiotherapy in Patient With Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinHodgkin LymphomaToxicity, Cardiac
A.O.U. Città della Salute e della Scienza 118
Testing effectiveness (Phase 2)Looking for participantsNCT05762900
What this trial is testing

Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients

Who this might be right for
Breast CancerRadiotherapy Side Effect
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 65
Not applicableLooking for participantsNCT04115267
What this trial is testing

Attribution of Toxicities Due to Radiotherapy and Immuno-Biological Therapies

Who this might be right for
CancerRadiotherapy Side Effect
Centre hospitalier de l'Université de Montréal (CHUM) 3,600
Testing effectiveness (Phase 2)UnknownNCT02244502
What this trial is testing

Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE)

Who this might be right for
Ovarian Carcinoma
NovoCure Ltd. 31
Not applicableUnknownNCT06549621
What this trial is testing

Cardiotoxicity of Carbon Monoxide in Patients Treated With Hyperbaric Oxygen Therapy

Who this might be right for
Carbon Monoxide Poisoning
University Hospital, Brest 66
Not applicableStudy completedNCT06522048
What this trial is testing

SJS/TEN or Other Cutaneous Adverse Eevents Induced by Immune Checkpoint Inhibitors (ICIs) vs. Non-ICIs

Who this might be right for
Immune Checkpoint Inhibitor-Induced DermatitisStevens-Johnson Syndrome, Drug-InducedToxic Epidermal Necrolysis Due to Drug
Chao Ji 300
Not applicableUnknownNCT00087815
What this trial is testing

Hyperbaric Oxygen Therapy in Treating Patients With Radiation Necrosis of the Brain

Who this might be right for
Brain and Central Nervous System TumorsCognitive/Functional EffectsRadiation Toxicity
Barrett Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00002663
What this trial is testing

Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies

Who this might be right for
EBV-induced LymphomasEBV-associated MalignanciesTransplant Patients With EBV Viremia at High Risk of Developing a Recurrent EBV Lymphoma
Atara Biotherapeutics 58
Testing effectiveness (Phase 2)Ended earlyNCT00019864
What this trial is testing

Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma

Who this might be right for
Cardiac ToxicitySarcoma
National Cancer Institute (NCI) 100
Next Page